Towa Pharmaceutical Co., Ltd. (TYO:4553)

Towa Pharmaceutical Revenue

In the fiscal year ending March 31, 2026, Towa Pharmaceutical had annual revenue of 273.71B JPY with 5.44% growth. Towa Pharmaceutical had revenue of 69.65B in the quarter ending March 31, 2026, with 5.75% growth.

• Revenue: 273.71B
• Revenue Growth: +5.44%
• P/S Ratio: 0.71
• Revenue / Employee: 57.17M
• Employees: 4,788
• Market Cap: 194.45B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	273.71B	14.12B	5.44%
Mar 31, 2025	259.59B	31.66B	13.89%
Mar 31, 2024	227.93B	19.08B	9.13%
Mar 31, 2023	208.86B	43.24B	26.11%
Mar 31, 2022	165.62B	10.72B	6.92%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error